Abstract | BACKGROUND: METHODS: Rats received an intravenous infusion of ESeroS-GS or saline, and underwent experimentally-induced renal I/R injury or sham treatment. Rats were sacrificed after 60 min of ischemia and 24 h of reperfusion. To evaluate the renal protective effects of ESero-GS, renal function was examined, kidneys were histologically assessed, levels of myeloperoxidase (MPO) and serum cytokines were measured, and caspase 3/7 activity was determined. RESULTS:
ESeroS-GS attenuated I/R-induced histologic alterations, reduced levels of MPO and serum BUN, Cre, TNF-α, and IL-6, and decreased caspase 3/7 activity in kidneys of rats subjected to renal I/R injury. CONCLUSIONS:
ESeroS-GS attenuated renal injury after I/R by reducing serum cytokine levels. Our findings suggest that ESeroS-GS may have therapeutic potential against various human I/R conditions.
|
Authors | Hironori Koga, Satoshi Hagiwara, Hideto Mei, Nozomi Hiraoka, Jyunya Kusaka, Koji Goto, Kenji Kashima, Takayuki Noguchi |
Journal | The Journal of surgical research
(J Surg Res)
Vol. 176
Issue 1
Pg. 220-5
(Jul 2012)
ISSN: 1095-8673 [Electronic] United States |
PMID | 22440932
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Elsevier Inc. All rights reserved. |
Chemical References |
- Benzopyrans
- Indoles
- Interleukin-6
- Tumor Necrosis Factor-alpha
- glutamyl-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-cysteinyl-glycine sodium salt
- Vitamin E
- Peroxidase
- Caspase 3
- Caspase 7
|
Topics |
- Animals
- Benzopyrans
(chemistry, pharmacology, therapeutic use)
- Blood Urea Nitrogen
- Caspase 3
(metabolism)
- Caspase 7
(metabolism)
- Indoles
(chemistry, pharmacology, therapeutic use)
- Interleukin-6
(blood)
- Kidney
(blood supply, drug effects, metabolism)
- Male
- Models, Animal
- Peroxidase
(metabolism)
- Rats
- Rats, Wistar
- Reperfusion Injury
(prevention & control)
- Tumor Necrosis Factor-alpha
(blood)
- Vitamin E
|